Rating #108
John Hussman
Hussman Strategic Advisors
Portfolio value
Stocks
Performance
1 Year
+16.76%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
John Hussman’s Portfolio: Q1 2026
Top10 stocks: 9.26% of the portfolio
John Hussman’s Trades: Q1 2026
Adds
New Buys
Sold Outs
Cuts
0.61ppt
0.83ppt
0.65ppt
0.47ppt
0.26ppt
0.49ppt
0.30ppt
0.30ppt
0.20ppt
0.46ppt
Company Name | Share Count Chg. (%) | Price Paid | Buy Value | Portfolio % Change | |
|---|---|---|---|---|---|
1  EPAM | Add +100.00% | $170.97 | $3.59M | 0.61ppt | |
2  CORT | Add +300.00% | $37.39 | $3.53M | 0.83ppt | |
3  PRLB | Add +100.00% | $58.03 | $3.05M | 0.65ppt | |
4  DG | Add +200.00% | $142.58 | $2.99M | 0.47ppt | |
5  QLYS | Add +150.00% | $110.82 | $2.79M | 0.26ppt | |
6  AAL | Add +100.00% | $13.25 | $2.78M | 0.49ppt | |
7  CPB | Add +100.00% | $25.68 | $2.70M | 0.30ppt | |
8  UPWK | Add +400.00% | $15.75 | $2.65M | 0.30ppt | |
9  WING | Add +166.67% | $240.35 | $2.52M | 0.20ppt | |
10  SYF | Add +100.00% | $72.72 | $2.29M | 0.46ppt |
John Hussman’s Holdings: Q1 2026
Company Name | Primary Industry | Avg. price paid  | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1 CORT | Pharmaceutical Pres | $36.49 | Add +300.00% | 126.00K | $5.08M | 1.10% 0.83ppt | 0.12% | 27 Quarters | Q1 2026 | |
2  UNFI | Wholesale-Grocery Line | $26.02 | Cut -16.67% | 105.00K | $4.73M | 1.02% -0.00ppt | 0.17% | 24 Quarters | Q1 2026 | |
3 CPB | Food Products | $31.89 | Add +100.00% | 210.00K | $4.68M | 1.01% 0.30ppt | 0.07% | 28 Quarters | Q1 2026 | |
4  APA | Crude Oil & Gas | $24.35 | 0.00% | 105.00K | $4.46M | 0.96% 0.34ppt | 0.03% | 3 Quarters | Q4 2025 | |
5  ETSY | Other Business Services | $54.83 | 0.00% | 84.00K | $4.20M | 0.91% -0.22ppt | 0.09% | 4 Quarters | Q4 2025 | |
6  ANIP | Pharmaceutical Pres | $78.12 | Add +66.67% | 52.50K | $4.04M | 0.87% 0.27ppt | 0.26% | 2 Quarters | Q1 2026 | |
7  CNXC | Other Business Services | $36.79 | Add +75.00% | 147.00K | $4.02M | 0.87% 0.03ppt | 0.24% | 5 Quarters | Q1 2026 | |
8  SEZL | Other Business Services | $73.08 | Add +20.00% | 63.00K | $3.99M | 0.86% 0.06ppt | 0.19% | 5 Quarters | Q1 2026 | |
9  ULTA | Other Retail-Stores | $522.71 | New Buy +100.00% | 7.35K | $3.84M | 0.83% 0.83ppt | 0.02% | 1 Quarter | Q1 2026 | |
10  PSIX | Engines & Turbines | $59.01 | Add +100.00% | 63.00K | $3.84M | 0.83% 0.39ppt | 0.27% | 2 Quarters | Q1 2026 | |
11 DG | Retail-Variety Stores | $113.60 | Add +200.00% | 31.50K | $3.74M | 0.81% 0.47ppt | 0.01% | 3 Quarters | Q1 2026 | |
12  ACAD | Pharmaceutical Pres | $22.13 | Add +14.29% | 168.00K | $3.74M | 0.81% -0.14ppt | 0.10% | 3 Quarters | Q1 2026 | |
13 QLYS | Prepackaged Software | $105.64 | Add +150.00% | 42.00K | $3.69M | 0.80% 0.26ppt | 0.12% | 3 Quarters | Q1 2026 | |
14  PGNY | Misc. Health Services | $20.12 | Add +66.67% | 210.00K | $3.57M | 0.77% -0.01ppt | 0.25% | 3 Quarters | Q1 2026 | |
15  AEO | Retail-Family Clothing | $16.70 | New Buy +100.00% | 210.00K | $3.51M | 0.76% 0.76ppt | 0.12% | 1 Quarter | Q1 2026 | |
16  COLL | Pharmaceutical Pres | $33.07 | New Buy +100.00% | 105.00K | $3.47M | 0.75% 0.75ppt | 0.33% | 1 Quarter | Q1 2026 | |
17  IRTC | Surgical Instruments | $147.73 | Add +100.00% | 29.40K | $3.47M | 0.75% 0.12ppt | 0.09% | 2 Quarters | Q1 2026 | |
18  INVA | Pharmaceutical Pres | $20.13 | Add +40.00% | 147.00K | $3.43M | 0.74% 0.23ppt | 0.22% | 22 Quarters | Q1 2026 | |
19  HALO | Biological products | $54.40 | 0.00% | 52.50K | $3.39M | 0.73% -0.12ppt | 0.04% | 16 Quarters | Q4 2025 | |
20  VSAT | Broadcasting Equipment | $31.88 | Cut -12.50% | 73.50K | $3.37M | 0.73% 0.03ppt | 0.06% | 6 Quarters | Q1 2026 |
NEWSLETTER
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersOur content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.